FeetMe, a Paris, France-based medical device company, raised €1.95m in seed funding.
The round was led by Kurma Diagnostics, with additional investment from the new Paris Saclay seed fund, Idinvest Partners, Seventure and SOSV (a current shareholder of FeetMe).
Led by Alexis Mathieu, founder and CEO, FeetMe produces smart and connected insoles for improved running, walking and gait analysis. The technology combines pressure sensors, motion sensors and learning algorithms to analyze patients’ functional capacity, as well as empower rehabilitation among sufferers of gait disorders.
The company intends to use the funds to pursue the development of its product to target therapeutics areas in collaboration with market players.